Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedles with Topical Botulinum Toxin for Palmar Hyperhidrosis
NCT03203174Phase 1Completed
- Sponsor
- University of California, Davis
- Start
- Jan 2015
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of botulinum toxin type A in palmar hyperhidrosis (PH) (2 cohorts), sponsored by University of California, Davis. Primary endpoints: Hyperhidrosis Disease Severity Scale at 1 month and Gravimetric Measurement of Sweat Production at 1 month. Started Jan 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
palmar hyperhidrosis (PH)
Beyond the preview
Go deeper on NCT03203174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03203174.